In melanoma, DNMTis, such as 5-azacytidine and Decitabine, incorporate into DNA and inhibit DNMT activity, leading to DNA hypermethylation that can reactivate tumor suppressor genes and anti-angiogenic factors. Here, DNMT1 is linked to melanoma.